Cargando…

Characteristics of colorectal carcinoma patients with PMS2 defects detected by immunohistochemistry

Lynch syndrome is the most prevalent form of familial colorectal cancer (CRC) and is caused by pathogenic germline mismatch repair (MMR) gene mutations. MLH1, MSH2 and MSH6 mutations have been well studied, but the rate and characteristics of PMS2 mutations are rare, especially in China. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Zhijun, Yan, Qijia, Chen, Guodong, Zhang, Xiaoli, Huang, Jia, Fu, Kai, Peng, Xiuda, Xiao, Shuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011511/
https://www.ncbi.nlm.nih.gov/pubmed/32826709
http://dx.doi.org/10.1097/CEJ.0000000000000620
_version_ 1783673237330198528
author Zeng, Zhijun
Yan, Qijia
Chen, Guodong
Zhang, Xiaoli
Huang, Jia
Fu, Kai
Peng, Xiuda
Xiao, Shuai
author_facet Zeng, Zhijun
Yan, Qijia
Chen, Guodong
Zhang, Xiaoli
Huang, Jia
Fu, Kai
Peng, Xiuda
Xiao, Shuai
author_sort Zeng, Zhijun
collection PubMed
description Lynch syndrome is the most prevalent form of familial colorectal cancer (CRC) and is caused by pathogenic germline mismatch repair (MMR) gene mutations. MLH1, MSH2 and MSH6 mutations have been well studied, but the rate and characteristics of PMS2 mutations are rare, especially in China. This study enrolled 1706 unselected patients with CRC who underwent colorectal resection from June 2016 to November 2018, the MMR status and clinicopathological features were analysed. A total of 11.8% of patients with CRC had defects in at least one MMR-related protein. Among them, 8.3% were identified with PMS2 defects, and 3.1% of patients had isolated PMS2 defects. Compared with MMR-proficient CRC, PMS2-defect CRC occurred more frequently in the right colon and less frequently in the rectum, had more poorly differentiated and mucinous carcinoma cases, and had fewer perineural invasions and a lower pN stage but a more advanced pT stage and a larger tumour size. In the cases with PMS2 defect, there were fewer tumours in the right colon, fewer poorly differentiated cases and smaller tumour sizes than in the cases with both MLH1 and PMS2 defects. In addition, in cases with isolated PMS2 defects, there were more tumours in the right colon and, more mucinous carcinoma cases than in cases with MMR-proficient CRCs, but had a similar cancer onset age. This study identified the rate, clinicopathological and age characteristics of PMS2 defects in CRCs in China and highlighted the importance of universal screening and germline detection of PMS2 in CRC.
format Online
Article
Text
id pubmed-8011511
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-80115112021-04-02 Characteristics of colorectal carcinoma patients with PMS2 defects detected by immunohistochemistry Zeng, Zhijun Yan, Qijia Chen, Guodong Zhang, Xiaoli Huang, Jia Fu, Kai Peng, Xiuda Xiao, Shuai Eur J Cancer Prev Gastrointestinal Cancer Lynch syndrome is the most prevalent form of familial colorectal cancer (CRC) and is caused by pathogenic germline mismatch repair (MMR) gene mutations. MLH1, MSH2 and MSH6 mutations have been well studied, but the rate and characteristics of PMS2 mutations are rare, especially in China. This study enrolled 1706 unselected patients with CRC who underwent colorectal resection from June 2016 to November 2018, the MMR status and clinicopathological features were analysed. A total of 11.8% of patients with CRC had defects in at least one MMR-related protein. Among them, 8.3% were identified with PMS2 defects, and 3.1% of patients had isolated PMS2 defects. Compared with MMR-proficient CRC, PMS2-defect CRC occurred more frequently in the right colon and less frequently in the rectum, had more poorly differentiated and mucinous carcinoma cases, and had fewer perineural invasions and a lower pN stage but a more advanced pT stage and a larger tumour size. In the cases with PMS2 defect, there were fewer tumours in the right colon, fewer poorly differentiated cases and smaller tumour sizes than in the cases with both MLH1 and PMS2 defects. In addition, in cases with isolated PMS2 defects, there were more tumours in the right colon and, more mucinous carcinoma cases than in cases with MMR-proficient CRCs, but had a similar cancer onset age. This study identified the rate, clinicopathological and age characteristics of PMS2 defects in CRCs in China and highlighted the importance of universal screening and germline detection of PMS2 in CRC. Lippincott Williams & Wilkins 2020-08-20 2021-05 /pmc/articles/PMC8011511/ /pubmed/32826709 http://dx.doi.org/10.1097/CEJ.0000000000000620 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CC-BY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Gastrointestinal Cancer
Zeng, Zhijun
Yan, Qijia
Chen, Guodong
Zhang, Xiaoli
Huang, Jia
Fu, Kai
Peng, Xiuda
Xiao, Shuai
Characteristics of colorectal carcinoma patients with PMS2 defects detected by immunohistochemistry
title Characteristics of colorectal carcinoma patients with PMS2 defects detected by immunohistochemistry
title_full Characteristics of colorectal carcinoma patients with PMS2 defects detected by immunohistochemistry
title_fullStr Characteristics of colorectal carcinoma patients with PMS2 defects detected by immunohistochemistry
title_full_unstemmed Characteristics of colorectal carcinoma patients with PMS2 defects detected by immunohistochemistry
title_short Characteristics of colorectal carcinoma patients with PMS2 defects detected by immunohistochemistry
title_sort characteristics of colorectal carcinoma patients with pms2 defects detected by immunohistochemistry
topic Gastrointestinal Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011511/
https://www.ncbi.nlm.nih.gov/pubmed/32826709
http://dx.doi.org/10.1097/CEJ.0000000000000620
work_keys_str_mv AT zengzhijun characteristicsofcolorectalcarcinomapatientswithpms2defectsdetectedbyimmunohistochemistry
AT yanqijia characteristicsofcolorectalcarcinomapatientswithpms2defectsdetectedbyimmunohistochemistry
AT chenguodong characteristicsofcolorectalcarcinomapatientswithpms2defectsdetectedbyimmunohistochemistry
AT zhangxiaoli characteristicsofcolorectalcarcinomapatientswithpms2defectsdetectedbyimmunohistochemistry
AT huangjia characteristicsofcolorectalcarcinomapatientswithpms2defectsdetectedbyimmunohistochemistry
AT fukai characteristicsofcolorectalcarcinomapatientswithpms2defectsdetectedbyimmunohistochemistry
AT pengxiuda characteristicsofcolorectalcarcinomapatientswithpms2defectsdetectedbyimmunohistochemistry
AT xiaoshuai characteristicsofcolorectalcarcinomapatientswithpms2defectsdetectedbyimmunohistochemistry